Brief: IO Biotech Announces Presentation Of New Data From MM1636 Phase 1/2 Clinical Trial Presented At 2022 AACR Annual Meeting
08/04/2022 21:29
April 8 (Reuters) - IO Biotech Inc IOBT.O :
* IO BIOTECH ANNOUNCES PRESENTATION OF NEW DATA FROM MM1636
PHASE
1/2 CLINICAL TRIAL PRESENTED AT 2022 AACR ANNUAL MEETING
Source text for Eikon: ID:nGNX9Xlkq5
Further company coverage: IOBT.O
((Reuters.Briefs@thomsonreuters.com;))